These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9522542)

  • 21. The differentiation between 'lack of insight' and 'dysfunctional health beliefs' in schizophrenia.
    Linden M; Godemann F
    Psychopathology; 2007; 40(4):236-41. PubMed ID: 17396050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When the side effect is really the symptom.
    Elder WG
    Am Fam Physician; 2002 Nov; 66(10):2008, 2010, 2013. PubMed ID: 12469971
    [No Abstract]   [Full Text] [Related]  

  • 24. The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.
    Kinon BJ; Ascher-Svanum H; Adams DH; Chen L
    J Clin Psychopharmacol; 2008 Oct; 28(5):544-9. PubMed ID: 18794651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders.
    Duncan JC; Rogers R
    J Forensic Sci; 1998 Nov; 43(6):1133-7. PubMed ID: 9846389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poison or cure: meanings of medication in schizophrenia.
    Rosenfield PJ
    J Am Acad Psychoanal Dyn Psychiatry; 2007; 35(2):189-201. PubMed ID: 17650972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
    Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
    Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Schizophrenic patient's constant refusal of psychotropic medication--case report and psychodynamic remarks].
    Murawiec S; Zechowski C
    Psychiatr Pol; 2007; 41(4):551-60. PubMed ID: 18046985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].
    Chéreau I; Gorwood P; Mouchabac S
    Encephale; 2009 Jan; Suppl 3():S97-100. PubMed ID: 19268186
    [No Abstract]   [Full Text] [Related]  

  • 31. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of antipsychotics to medication regimens during schizophrenic inpatient care.
    Koyama A; Ito H; Nakanishi M; Sawamura K; Higuchi T
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):56-64. PubMed ID: 18289142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies.
    Emsley R; Berwaerts J; Eerdekens M; Kramer M; Lane R; Lim P; Hough D; Palumbo J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):343-56. PubMed ID: 18854723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insight and schizophrenia.
    Buckley PF; Hasan S; Friedman L; Cerny C
    Compr Psychiatry; 2001; 42(1):39-41. PubMed ID: 11154714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitude toward medication and perceived competence among chronically psychotic patients.
    Todman M; Gordon-Leeds D; Taylor S
    Psychol Rep; 1997 Jun; 80(3 Pt 1):809-10. PubMed ID: 9198382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jun; 145(24):1281-3. PubMed ID: 15264758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.